TI
BLUE

Turner Investments’s bluebird bio BLUE Stock Holding History

Turner Investments’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-135
Closed -$184K – 101
2017
Q2 		$184K Buy
+135
New +$163K 0.12% 196
2017
Q1 		– Sell
-1,623
Closed -$1.3M – 223
2016
Q4 		$1.3M Buy
1,623
+1,584
+4,062% +$1.26M 0.52% 78
2016
Q3 		$34K Hold
39
– – 0.01% 175
2016
Q2 		$22K Sell
39
-2,191
-98% -$1.24M 0.01% 196
2016
Q1 		$1.23M Buy
2,230
+2,211
+11,637% +$1.36M 0.33% 98
2015
Q4 		$16K Buy
+19
New +$19K ﹤0.01% 214

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Turner Investments's BLUE Position: Q3 2017 in Review

Turner Investments sold out of bluebird bio (BLUE) in Q3 2017, closing a stake of 135 shares — an estimated $184K sold.

Turner Investments first reported a position in BLUE in Q4 2015 and held it in 6 quarters. The position peaked at $1.3M in Q4 2016. 243 funds tracked by Wall St. Rank hold BLUE as of Q3 2017.

  • Turner Investments reported no remaining bluebird bio position as of Q3 2017 after selling out during the quarter.
  • Turner Investments sold 135 bluebird bio shares in Q3 2017, an estimated $184K.
  • Turner Investments first reported a position in bluebird bio in Q4 2015 and held it in 6 quarters.
  • Turner Investments's bluebird bio position peaked at $1.3M in Q4 2016.
  • 243 funds tracked by Wall St. Rank held bluebird bio as of Q3 2017.

Based on Turner Investments's 13F filing for Q3 2017, filed 8 Nov 2017.